SCHEMBL698993

SCHEMBL698993

NC(=O)C(O)C(O)C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.67
ACHE P22303 1/20 0.38
TP53 P04637 1/20 0.37
CYP2C9 P11712 1/20 0.36
PDE4A P27815 1/20 0.36
NFKB1 P19838 2/20 0.34
PGD P52209 1/20 0.34
CYP2C19 P33261 1/20 0.34
LDHA P00338 1/20 0.33
LDHB P07195 1/20 0.33
KDM4E B2RXH2 2/20 0.32
BLM P54132 2/20 0.32
PMP22 Q01453 2/20 0.32
HIF1A Q16665 2/20 0.32
LMNA P02545 2/20 0.32
RECQL P46063 2/20 0.32
MAPK1 P28482 1/20 0.32
THPO P40225 1/20 0.32
HSD17B10 Q99714 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15510244 0.97 TSHR (0.62) TSHRACHETP53CYP2C9PDE4A
Cadaverine Tartrate SCHEMBL22076336 0.86 TSHR (0.77) TSHRACHETP53CYP2C9PDE4A
Cadaverine Tartrate SCHEMBL17338130 0.86 TSHR (0.77) TSHRACHETP53CYP2C9PDE4A
SCHEMBL77247 0.86 LMNA (0.42) TSHRACHENFKB1PGDLDHA
SCHEMBL7093505 0.86 LMNA (0.42) TSHRACHENFKB1PGDLDHA
SCHEMBL1874716 0.86 LMNA (0.42) TSHRACHENFKB1PGDLDHA
Cadaverine Tartrate SCHEMBL28932383 0.82 TSHR (0.83) TSHRACHETP53CYP2C9PDE4A
Cadaverine Tartrate SCHEMBL28636687 0.82 TSHR (0.83) TSHRACHETP53CYP2C9PDE4A
Cadaverine Tartrate SCHEMBL2276011 0.82 TSHR (0.83) TSHRACHETP53CYP2C9PDE4A
Cadaverine Tartrate SCHEMBL15660786 0.82 TSHR (0.83) TSHRACHETP53CYP2C9PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119775844-A Anti-aging photochromic lens and preparation method thereof 江苏全真光学科技股份有限公司 2025-04-08 CN claimed
US-20240165291-A1 SUPERABSORBENT CHITOSAN WOUND DRESSINGS, MANUFACTURING METHODS AND APPLICATIONS THEREOF ADVAMEDICA INC. 2024-05-23 US claimed
CN-116875162-B Photochromic lens in car and preparation process thereof 江苏励杰光电科技有限公司 2024-05-14 CN claimed
CN-117343232-A Epoxy modified acrylic acid aqueous dispersion 湖北双键精细化工有限公司 2024-01-05 CN claimed
CN-116444738-B Epoxy modified acrylic acid aqueous dispersion and preparation method thereof 泰兴盛嘉树脂有限公司 2023-12-26 CN claimed
CN-116875162-A Photochromic lens in car and preparation process thereof 江苏励杰光电科技有限公司 2023-10-13 CN claimed
CN-116813914-A Polyurethane hard foam stabilizer and preparation method thereof 山东思德新材料科技有限公司 2023-09-29 CN claimed
CN-115353853-B Double-component polyurethane adhesive and preparation method and application thereof 杭州之江有机硅化工有限公司 2023-08-01 CN claimed
CN-116444738-A Epoxy modified acrylic acid aqueous dispersion and preparation method thereof 泰兴盛嘉树脂有限公司 2023-07-18 CN claimed
CN-115245590-A Novel degradable embolism microsphere and preparation method thereof 苏州浩微生物医疗科技有限公司 2022-10-28 CN claimed
CN-108671849-A A kind of anionic gemini surfactant and preparation method thereof 东华大学 2018-10-19 CN claimed
CN-105232467-B Polyacrylamide gel dispersion instant solid composite and preparation method thereof 佛山市顺德区易优生物医药有限公司 2018-06-26 CN claimed
CN-106575775-A covalently cross-linked gel electrolyte 安特克研发国际公司 2017-04-19 CN claimed
CN-105232467-A Polyacrylamide gel peptization instant solid composite and preparing method thereof Zheng shanshui 2016-01-13 CN claimed
US-20100210848-A1 PROCESS FOR OPTICALLY ACTIVE SULFOXIDE COMPOUNDS IPCA LABORATORIES LTD. (IN) 2010-08-19 US claimed
EP-1457487-A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE CIS-PIPERIDINE DERIVATIVES Toray Fine Chemicals Co., Ltd. (JP) 2004-09-15 EP claimed
US-20040171836-A1 Method for producing optical-active cis-piperidine derivatives TORAY FINE CHEMICALS CO., LTD., A CORPORATION OF JAPAN, (JP) 2004-09-02 US claimed
US-5306844-A Tartaric acid amide derivative and method of producing the same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1994-04-26 US claimed
EP-0298695-B1 TARTARIC ACID AMIDE DERIVATIVE AND METHOD OF PRODUCING THE SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1993-05-12 EP claimed
EP-0298695-A2 Tartaric acid amide derivative and method of producing the same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1989-01-11 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040171836-A1 Method for producing optical-active cis-piperidine derivatives TYR, DDC, TARBP1 TSHR 1512/4885ACHE 270/4885TP53 1309/4885
US-20100210848-A1 PROCESS FOR OPTICALLY ACTIVE SULFOXIDE COMPOUNDS PPOX, PPIH, SQOR TSHR 2279/4885ACHE 2056/4885TP53 4335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.